Rajiv Kumar

Dana-Farber Cancer Institute

Papers

1

Total Citations

168

H-Index

1

About

Dr. Rajiv Kumar is a leading figure in nanomedicine, with a primary focus on advancing cancer therapy through the innovative use of gold nanoparticles. His seminal 2014 review, "Targeted Radiotherapy with Gold Nanoparticles: Current Status and Future Perspectives," has garnered over 168 citations, establishing a foundational framework for the field. Dr. Kumar’s major contributions lie in demonstrating how gold nanoparticles can be engineered to enhance the precision of radiation therapy, effectively concentrating cytotoxic energy within tumor cells while minimizing damage to surrounding healthy tissue. This work directly addresses the central challenge of radiotherapy: maximizing tumor destruction while reducing side effects. Beyond this key paper, his research portfolio explores the synthesis and functionalization of nanoparticles for targeted drug delivery and imaging, bridging the gap between materials science and clinical oncology. Dr. Kumar’s insights have not only shaped current experimental protocols but have also guided the strategic direction of theranostic applications, making him a highly cited and influential voice for students and researchers seeking to understand the future of nanoparticle-assisted cancer treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
168
Total Citations
168
Avg Citations/Paper
🏆 Most Cited Paper
Targeted Radiotherapy with Gold Nanoparticles: Current Status and Future Perspectives
168 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Dana-Farber Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago